D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 73 Citations 17,190 287 World Ranking 13458 National Ranking 7099

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Surgery

His main research concerns Prostate cancer, Surgery, Internal medicine, Urology and Prostate-specific antigen. Scott E. Eggener interconnects Biopsy, Radiology and Prostate in the investigation of issues within Prostate cancer. His Biopsy study combines topics from a wide range of disciplines, such as Prostate biopsy and Image-Guided Biopsy.

His Surgery research is multidisciplinary, incorporating elements of Prostatectomy, Kidney cancer, Kidney disease and Metastasis. His studies deal with areas such as Survival rate, Perioperative, Urinary incontinence and Oncology as well as Prostatectomy. His work deals with themes such as Transitional cell carcinoma, Predictive value of tests, Urine cytology, Cytology and Carcinoma, which intersect with Urology.

His most cited work include:

  • MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis (876 citations)
  • POTENCY, CONTINENCE AND COMPLICATIONS IN 3,477 CONSECUTIVE RADICAL RETROPUBIC PROSTATECTOMIES (476 citations)
  • Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy (455 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Prostate cancer, Internal medicine, Surgery, Urology and Oncology. His studies in Prostate cancer integrate themes in fields like Biopsy and Prostate. His Prostate study incorporates themes from Ablation, Magnetic resonance imaging, Radiology and Nuclear medicine.

The concepts of his Surgery study are interwoven with issues in Urinary system, Nephrectomy and Cohort. His Positive Surgical Margin research extends to the thematically linked field of Urology. His Prostatectomy study integrates concerns from other disciplines, such as Odds ratio, Urinary incontinence, Radiation therapy and Nomogram.

He most often published in these fields:

  • Prostate cancer (44.50%)
  • Internal medicine (36.60%)
  • Surgery (25.60%)

What were the highlights of his more recent work (between 2016-2021)?

  • Prostate cancer (44.50%)
  • Internal medicine (36.60%)
  • Oncology (22.73%)

In recent papers he was focusing on the following fields of study:

Scott E. Eggener mostly deals with Prostate cancer, Internal medicine, Oncology, Prostate and Radiology. His study involves Prostatectomy and Prostate-specific antigen, a branch of Prostate cancer. His work carried out in the field of Prostatectomy brings together such families of science as Randomized controlled trial, Logistic regression, Incidence and Urology.

As a part of the same scientific family, Scott E. Eggener mostly works in the field of Internal medicine, focusing on Guideline and, on occasion, Molecular biomarkers and Standard treatment. His work on Adjuvant as part of general Oncology research is frequently linked to Identification, bridging the gap between disciplines. In the subject of general Prostate, his work in Prostate biopsy is often linked to Laser ablation, thereby combining diverse domains of study.

Between 2016 and 2021, his most popular works were:

  • MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis (876 citations)
  • Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline (146 citations)
  • New and Established Technology in Focal Ablation of the Prostate: A Systematic Review (142 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

Prostate cancer, Internal medicine, Oncology, Magnetic resonance imaging and Prostatectomy are his primary areas of study. His work on Prostate-specific antigen as part of general Prostate cancer research is often related to Context, thus linking different fields of science. Scott E. Eggener has included themes like Gastroenterology and Guideline in his Internal medicine study.

In his research on the topic of Oncology, Consensus conference and Germline is strongly related with Genetic testing. His biological study deals with issues like Medical physics, which deal with fields such as Radical treatment and Delphi method. His Prostatectomy research incorporates themes from Logistic regression, Cohort and Urology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

Veeru Kasivisvanathan;Antti S. Rannikko;Marcelo Borghi;Valeria Panebianco.
The New England Journal of Medicine (2018)

1293 Citations

POTENCY, CONTINENCE AND COMPLICATIONS IN 3,477 CONSECUTIVE RADICAL RETROPUBIC PROSTATECTOMIES

Shilajit D. Kundu;Kimberly A. Roehl;Scott E. Eggener;Jo Ann V. Antenor.
The Journal of Urology (2004)

629 Citations

Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy

Scott E. Eggener;Peter T. Scardino;Patrick C. Walsh;Misop Han.
The Journal of Urology (2011)

607 Citations

Focal Therapy for Localized Prostate Cancer: A Critical Appraisal of Rationale and Modalities

Scott E. Eggener;Peter T. Scardino;Peter R. Carroll;Michael J. Zelefsky.
The Journal of Urology (2007)

380 Citations

Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group.

Caroline M. Moore;Veeru Kasivisvanathan;Scott Eggener;Mark Emberton.
European Urology (2013)

379 Citations

The role of SPINK1 in ETS rearrangement-negative prostate cancers.

Scott A. Tomlins;Daniel R. Rhodes;Jianjun Yu;Sooryanarayana Varambally.
Cancer Cell (2008)

362 Citations

Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance.

Ryan K. Berglund;Timothy A. Masterson;Kinjal C. Vora;Scott E. Eggener.
The Journal of Urology (2008)

308 Citations

Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR

Andrew B. Rosenkrantz;Sadhna Verma;Peter Choyke;Steven C. Eberhardt.
The Journal of Urology (2016)

300 Citations

Positive Surgical Margins at Partial Nephrectomy: Predictors and Oncological Outcomes

Ofer Yossepowitch;R. Houston Thompson;Bradley C. Leibovich;Scott E. Eggener.
The Journal of Urology (2008)

281 Citations

Diffusion-Weighted and Dynamic Contrast-Enhanced MRI of Prostate Cancer: Correlation of Quantitative MR Parameters With Gleason Score and Tumor Angiogenesis

Aytekin Oto;Cheng Yang;Arda Kayhan;Maria Tretiakova.
American Journal of Roentgenology (2011)

274 Citations

Best Scientists Citing Scott E. Eggener

Mark Emberton

Mark Emberton

University College London

Publications: 172

Hashim U. Ahmed

Hashim U. Ahmed

Imperial College Healthcare NHS Trust

Publications: 166

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 137

Alberto Briganti

Alberto Briganti

Vita-Salute San Raffaele University

Publications: 134

Shahrokh F. Shariat

Shahrokh F. Shariat

Medical University of Vienna

Publications: 119

Baris Turkbey

Baris Turkbey

National Institutes of Health

Publications: 94

Morgan Rouprêt

Morgan Rouprêt

Université Paris Cité

Publications: 84

Declan G. Murphy

Declan G. Murphy

Peter MacCallum Cancer Centre

Publications: 80

Markus Graefen

Markus Graefen

Universität Hamburg

Publications: 79

Pierre I. Karakiewicz

Pierre I. Karakiewicz

University of Montreal

Publications: 79

Stephen J. Freedland

Stephen J. Freedland

Cedars-Sinai Medical Center

Publications: 75

James A. Eastham

James A. Eastham

Memorial Sloan Kettering Cancer Center

Publications: 74

Peter L. Choyke

Peter L. Choyke

National Institutes of Health

Publications: 74

Peter R. Carroll

Peter R. Carroll

University of California, San Francisco

Publications: 68

Michael J. Joyner

Michael J. Joyner

Mayo Clinic

Publications: 67

Peter T. Scardino

Peter T. Scardino

Memorial Sloan Kettering Cancer Center

Publications: 63

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.